Handelsbanken Fonder’s Hims & Hers Health HIMS Stock Holding History

Handelsbanken Fonder’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	60,000 +2,300	+4%	+$61.7K	0.01%	797
2026 Q1	$1.2M	Buy	57,700 +300	+0.5%	+$7.09K	﹤0.01%	964
2025 Q4	$1.86M	Buy	57,400 +7,700	+15%	+$330K	0.01%	770
2025 Q3	$2.82M	Buy	49,700 +4,400	+10%	+$225K	0.01%	623
2025 Q2	$2.26M	Buy	45,300 +4,200	+10%	+$190K	0.01%	620
2025 Q1	$1.22M	Buy	41,100 +7,700	+23%	+$286K	0.01%	853
2024 Q4	$808K	Buy	33,400 +6,600	+25%	+$164K	﹤0.01%	1072
2024 Q3	$494K	Hold	26,800	–	–	﹤0.01%	1248
2024 Q2	$541K	Hold	26,800	–	–	﹤0.01%	1124
2024 Q1	$415K	Hold	26,800	–	–	﹤0.01%	1245
2023 Q4	$239K	Hold	26,800	–	–	﹤0.01%	1472
2023 Q3	$169K	Hold	26,800	–	–	﹤0.01%	1503
2023 Q2	$252K	Sell	26,800 -5,200	-16%	-$51.6K	﹤0.01%	1411
2023 Q1	$317K	Hold	32,000	–	–	﹤0.01%	1265
2022 Q4	$205K	Hold	32,000	–	–	﹤0.01%	1429
2022 Q3	$179K	Hold	32,000	–	–	﹤0.01%	1455
2022 Q2	$145K	Hold	32,000	–	–	﹤0.01%	1543
2022 Q1	$171K	Hold	32,000	–	–	﹤0.01%	1649
2021 Q4	$210K	Buy	+32,000	New	+$231K	﹤0.01%	1694

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Handelsbanken Fonder's HIMS Position: Q2 2026 in Review

Handelsbanken Fonder increased its Hims & Hers Health (HIMS) stake by 4% in Q2 2026, buying an estimated $61.7K and bringing the position to 60,000 shares worth $2.08M. The position accounts for 0.01% of the portfolio, ranked #797.

Handelsbanken Fonder first reported a position in HIMS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.82M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Handelsbanken Fonder held 60,000 shares of Hims & Hers Health worth $2.08M as of Q2 2026.
Handelsbanken Fonder bought 2,300 Hims & Hers Health shares in Q2 2026, an estimated $61.7K.
Hims & Hers Health made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #797 holding.
Handelsbanken Fonder first reported a position in Hims & Hers Health in Q4 2021 and has held it in 19 quarters since.
Handelsbanken Fonder's Hims & Hers Health position peaked at $2.82M in Q3 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.